MA42914A - Composés tricycliques et leur utilisation dans le traitement du cancer - Google Patents
Composés tricycliques et leur utilisation dans le traitement du cancerInfo
- Publication number
- MA42914A MA42914A MA042914A MA42914A MA42914A MA 42914 A MA42914 A MA 42914A MA 042914 A MA042914 A MA 042914A MA 42914 A MA42914 A MA 42914A MA 42914 A MA42914 A MA 42914A
- Authority
- MA
- Morocco
- Prior art keywords
- cancer
- treatment
- tricyclic compounds
- tricyclic
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1514018.9A GB201514018D0 (en) | 2015-08-07 | 2015-08-07 | Novel tricyclic compounds and their use in the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA42914A true MA42914A (fr) | 2018-08-01 |
Family
ID=54200421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA042914A MA42914A (fr) | 2015-08-07 | 2016-08-05 | Composés tricycliques et leur utilisation dans le traitement du cancer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10881653B2 (fr) |
| EP (1) | EP3331883A1 (fr) |
| JP (1) | JP6545908B2 (fr) |
| KR (2) | KR20180032647A (fr) |
| CN (1) | CN108026096A (fr) |
| AU (1) | AU2016307438B2 (fr) |
| CA (1) | CA2995075C (fr) |
| GB (1) | GB201514018D0 (fr) |
| MA (1) | MA42914A (fr) |
| MX (1) | MX2018001575A (fr) |
| RU (1) | RU2736501C2 (fr) |
| WO (1) | WO2017027358A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA51821A (fr) * | 2018-02-12 | 2020-12-23 | Cinda Pharma Ab | Inhibiteurs de la thiorédoxine réductase à utiliser dans le traitement du cancer |
| CA3113234A1 (fr) | 2018-09-18 | 2020-03-26 | Nikang Therapeutics, Inc. | Derives heteroaryles tri-substitues utilises en tant qu'inhibiteurs de la phosphatase src a homologie-2 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7550458B2 (en) | 2005-10-18 | 2009-06-23 | Bristol-Myers Squibb Company | Tricycloundecane compounds useful as modulators of nuclear hormone receptor function |
| WO2008027912A2 (fr) | 2006-08-28 | 2008-03-06 | Dan Theodorescu | Prédiction de l'activité d'agents sur différents types de cellules et de tissus |
| PL219045B1 (pl) | 2010-10-16 | 2015-03-31 | Inst Chemii Organicznej Polskiej Akademii Nauk | Nowe estry (acyloksymetylo)akrylamidu, kompozycja farmaceutyczna zawierająca je oraz ich zastosowanie |
-
2015
- 2015-08-07 GB GBGB1514018.9A patent/GB201514018D0/en not_active Ceased
-
2016
- 2016-08-05 MA MA042914A patent/MA42914A/fr unknown
- 2016-08-05 WO PCT/US2016/045730 patent/WO2017027358A1/fr active Application Filing
- 2016-08-05 MX MX2018001575A patent/MX2018001575A/es unknown
- 2016-08-05 JP JP2018526610A patent/JP6545908B2/ja active Active
- 2016-08-05 KR KR1020187006528A patent/KR20180032647A/ko not_active IP Right Cessation
- 2016-08-05 EP EP16751126.0A patent/EP3331883A1/fr not_active Withdrawn
- 2016-08-05 KR KR1020207024002A patent/KR102428549B1/ko active IP Right Grant
- 2016-08-05 RU RU2018107941A patent/RU2736501C2/ru active
- 2016-08-05 CN CN201680046578.8A patent/CN108026096A/zh active Pending
- 2016-08-05 CA CA2995075A patent/CA2995075C/fr active Active
- 2016-08-05 US US15/750,819 patent/US10881653B2/en active Active
- 2016-08-05 AU AU2016307438A patent/AU2016307438B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017027358A1 (fr) | 2017-02-16 |
| EP3331883A1 (fr) | 2018-06-13 |
| US20200113889A1 (en) | 2020-04-16 |
| CN108026096A (zh) | 2018-05-11 |
| JP6545908B2 (ja) | 2019-07-17 |
| CA2995075A1 (fr) | 2017-02-16 |
| CA2995075C (fr) | 2022-05-31 |
| KR20200102529A (ko) | 2020-08-31 |
| RU2018107941A (ru) | 2019-09-09 |
| KR102428549B1 (ko) | 2022-08-03 |
| AU2016307438A1 (en) | 2018-02-22 |
| AU2016307438B2 (en) | 2019-07-11 |
| GB201514018D0 (en) | 2015-09-23 |
| RU2018107941A3 (fr) | 2019-09-09 |
| RU2736501C2 (ru) | 2020-11-17 |
| MX2018001575A (es) | 2018-11-09 |
| KR20180032647A (ko) | 2018-03-30 |
| JP2018522948A (ja) | 2018-08-16 |
| WO2017027358A8 (fr) | 2017-05-11 |
| US10881653B2 (en) | 2021-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39960A (fr) | Composés imidazo[4,5c]quinoline-2-one et leur utilisation dans le traitement du cancer | |
| FR22C1011I2 (fr) | Promedicaments de fumarates et leur utilisation pour le traitement de diverses maladies | |
| MA43163A (fr) | Polypeptides à domaine extracellulaire cd80 et leur utilisation dans le traitement du cancer | |
| MA45122A (fr) | Inhibiteurs hétérocycliques de cbp/ep300 et leur utilisation dans le traitement du cancer | |
| MA52886A (fr) | Composés de purinone et leur utilisation dans le traitement du cancer | |
| MA43135A (fr) | Compositions et méthodes pour le du traitement du cancer | |
| MA44225A (fr) | Sulfonylurées et composés apparentés et leur utilisation | |
| MA49144A (fr) | Polythérapies pour le traitement du cancer | |
| MA43283A (fr) | Procédés et compositions pour le traitement du cancer | |
| MA42420A (fr) | Vaccins pour le traitement et la prévention du cancer | |
| MA41449A (fr) | Polythérapies pour le traitement de cancers | |
| MA45613A (fr) | Composés polycycliques-carbamoylpyridones et leur utilisation pharmaceutique | |
| MA41044A (fr) | Compositions et procédés d'utilisation pour une réponse immunitaire accrue et traitement contre le cancer | |
| MA45709A (fr) | Composés diazahétérobicycliques substitués et leur utilisation | |
| MA42915A (fr) | Pyridines et leur utilisation dans le traitement du cancer | |
| FI20145195A (fi) | Eutektiset liuotinseokset ja niiden käyttö | |
| MA47450A (fr) | Sulfinylpyridines et leur utilisation dans le traitement du cancer | |
| MA41316A (fr) | Gènes de détermination du sexe et leur utilisation en reproduction | |
| MA48637A (fr) | Polythérapies pour le traitement du cancer | |
| MA50409A (fr) | Polythérapies pour le traitement du cancer | |
| MA45675A (fr) | Méthodes et compositions permettant le traitement du cancer | |
| MA47408A (fr) | Traitement du cancer | |
| MA47452A (fr) | Pyridines à substitution hétérocyclylsulfonyle et leur utilisation dans le traitement du cancer | |
| MA45046A (fr) | Irinotécan nanoliposomal utilisé dans le traitement du cancer bronchique à petites cellules | |
| MA47458A (fr) | Pyridines à substitution hydrocarbylsulfonyle et leur utilisation dans le traitement du cancer |